Convertible Promissory Notes and Notes Payable (Details Narrative) - USD ($)	1 Months Ended				6 Months Ended	9 Months Ended
	Feb. 22, 2023	Oct. 31, 2022	Oct. 19, 2022	Jun. 30, 2022	Dec. 31, 2022	Mar. 31, 2024	Mar. 31, 2023	Jan. 18, 2024	Jun. 30, 2023	Apr. 15, 2022	Aug. 01, 2021
Proceeds from related party						$ 0	$ 1,470,000
Common stock per share						$ 0.001		$ 0.9868	$ 0.001
Interest rate				8.50%
Upexi Enterprises, LLC [Member]
Promissory notes Principal amount		$ 5,750,000
Promissory notes maturity date		12 months
Common stock conversion price		$ 4.81
Interest rate		4.00%
Upexi Enterprises, LLC One [Member]
Promissory notes Principal amount		$ 5,750,000
Promissory notes maturity date		24 months
Interest rate		4.00%
Upexi Enterprises, LLC Two [Member]
Promissory notes Principal amount		$ 3,500,000
Promissory notes maturity date		36 months
Interest rate		0.00%
Promissory note Feb 22, 2023 [Member]
Promissory notes Principal amount	$ 560,000
Description of amendment to the promissory note	the Company executed an amendment to the promissory note with the investor, providing for the payment of interest only for 18 months at 12% per annum and thereafter the amortization of the note over a 12-month period, starting in June of 2025
Principal outstanding amount	$ 560,000
Common stock share purchase	125,000
Common stock per share	$ 1.10
Promissory note Feb 22, 2023 One [Member]
Promissory notes Principal amount	$ 2,150,000
Description of amendment to the promissory note	the Company executed an amendment to the promissory note with the investor, providing for the payment of interest only for 18 months at 12% per annum and thereafter the amortization of the note over a 12-month period, starting in June of 2025
Principal outstanding amount	$ 2,150,000
Common stock share purchase	500,000
Common stock per share	$ 1.10
Allan Marshall [Member]
Promissory notes Principal amount				$ 1,500,000
Description of amendment to the promissory note				the Company executed an amendment to the promissory note with Mr. Marshall, providing for the payment of interest only for 18 months at an interest rate of 12% per annum and thereafter the amortization of the note over a 12 month period, starting in June of 2025
Principal outstanding amount				$ 1,500,000
Common stock share purchase				375,000
Common stock per share				$ 1.10
Interest rate				8.50%
Interest rate pik				3.50%
VitaMedica Note [Member]
Promissory notes Principal amount											$ 500,000
Common stock per share											$ 5.00
Total convertible common stock											$ 100,000
Cygnet Note [Member]
Promissory notes Principal amount										$ 1,050,000
Common stock per share										$ 6.00
Convertible Notes, 36-Month Term Notes [Member]
Proceeds from related party				$ 7,500,000
Fund received from accredited investors				15,000,000
Proceeds from notes			$ 2,780,200	6,678,506
Description of agreement			The Company received a forbearance agreement from the bank until June 30, 2024 to return to compliance of the debt service ratio of 1.25 to 1, until that time the Company will pay an interest rate of 10% instead of the contractual terms of 4.8%
Holdback amount			$ 3,000,000
Warrants acquire				$ 56,250
Exercise price				$ 4.44
Gain in the change of derivative liability					$ 3,540
Redeem warrants				$ 250,000
Note Agreement [Member]
Holdback amount				$ 500,000